𝐖𝐨𝐫𝐥𝐝’𝐬 𝐟𝐢𝐫𝐬𝐭-𝐞𝐯𝐞𝐫 𝐦𝐚𝐥𝐚𝐫𝐢𝐚 𝐝𝐫𝐮𝐠 𝐟𝐨𝐫 𝐧𝐞𝐰𝐛𝐨𝐫𝐧𝐬 𝐚𝐩𝐩𝐫𝐨𝐯𝐞𝐝

Drug manufacturer Novartis has received approval from Swiss authorities for its new malaria drug named Coartem.

Malaria accounted for more than half a million deaths worldwide in 2023.